New Drug Holds Some Promise for Treatment-Failure Gout

New Drug Holds Some Promise for Treatment-Failure Gout

IV pegloticase every 2 to 4 weeks effectively controlled uric acid levels, but the incidence of adverse events was high.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:NEJM journal watch. General medicine 2008-12
1. Verfasser: DeMarco, Deborah M
Format: Artikel
Sprache:eng
Schlagworte:
Clinical trials
Medical research
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:IV pegloticase every 2 to 4 weeks effectively controlled uric acid levels, but the incidence of adverse events was high.
ISSN:2329-2865